Natco Pharma net profit increased 11.85 per cent at ₹217 crore in the third quarter ended December 31, 2017, against ₹194 crore in the corresponding quarter of the previous year. Total revenue, however, declined from ₹685 crore to ₹573 crore.
The board of directors has declared second interim dividend of ₹7 on each equity share of ₹2 each for the year 2017-18 which is 350 per cent on the nominal value of the share.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.